Survival Benefits of Metformin for Colorectal Cancer Patients with Diabetes: A Systematic Review and Meta-Analysis

Survival Benefits of Metformin for Colorectal Cancer Patients with Diabetes: A Systematic Review and Meta-Analysis

Bibliographic Details
Main Authors:	Mei, Zu-Bing, Zhang, Zhi-Jiang, Liu, Chen-Ying, Liu, Yun, Cui, Ang, Liang, Zhong-Lin, Wang, Guang-Hui, Cui, Long
Format:	Online
Language:	English
Published:	Public Library of Science 2014
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3960145/

Similar Items

Correction: Survival Benefits of Metformin for Colorectal Cancer Patients with Diabetes: A Systematic Review and Meta-Analysis
Published: (2014)

Metformin Is Associated With Slightly Reduced Risk of Colorectal Cancer and Moderate Survival Benefits in Diabetes Mellitus: A Meta-Analysis
by: He, Xing-kang, et al.
Published: (2016)

Tumour-infiltrating inflammation and prognosis in colorectal cancer: systematic review and meta-analysis
by: Mei, Z, et al.
Published: (2014)

Reduced Risk of Colorectal Cancer With Metformin Therapy in Patients With Type 2 Diabetes: A meta-analysis
by: Zhang, Zhi-Jiang, et al.
Published: (2011)

Survival Benefit of Metformin Adjuvant Treatment For Pancreatic Cancer Patients: a Systematic Review and Meta-Analysis
by: Guoxing Wan, et al.
Published: (2018-09-01)

Metformin therapy associated with survival benefit in lung cancer patients with diabetes
by: Wan, Guoxing, et al.
Published: (2016)

Response to comment on ‘Tumour-infiltrating inflammation and prognosis in colorectal cancer: systematic review and meta-analysis'
by: Mei, Z, et al.
Published: (2014)

Metformin Beyond Diabetes: Pleiotropic Benefits of Metformin in Attenuation of Atherosclerosis
by: Forouzandeh, Farshad, et al.
Published: (2014)

Survival Benefit and Safety of No. 10 Lymphadenectomy for Gastric Cancer Patients With Total Gastrectomy
by: Yang, Kun, et al.
Published: (2014)

Survival Benefits of Western and Traditional Chinese Medicine Treatment for Patients With Pancreatic Cancer
by: Yang, Xue, et al.
Published: (2015)

Understanding the benefit of metformin use in cancer treatment
by: Dowling, Ryan JO, et al.
Published: (2011)

Upregulation of spondin-2 predicts poor survival of colorectal carcinoma patients
by: Zhang, Qian, et al.
Published: (2015)

Loss of nuclear localization of TET2 in colorectal cancer
by: Huang, Yuji, et al.
Published: (2016)

Time to benefit for colorectal cancer screening: survival meta-analysis of flexible sigmoidoscopy trials
Published: (2015)

Time to benefit for colorectal cancer screening: survival meta-analysis of flexible sigmoidoscopy trials
by: Tang, Victoria, et al.
Published: (2015)

Metformin and Colorectal Cancer Risk in Diabetic Patients
by: Ioannou, George N., et al.
Published: (2011)

Benefits of Therapeutic Drug Monitoring of Vancomycin: A Systematic Review and Meta-Analysis
by: Ye, Zhi-Kang, et al.
Published: (2013)

Colorectal and Prostate Cancer Risk in Diabetes: Metformin, an Actor behind the Scene
by: Anwar, M. Akhtar, et al.
Published: (2014)

Metformin vs Insulin in the Management of Gestational Diabetes: A Meta-Analysis
by: Gui, Juan, et al.
Published: (2013)

The survival benefit and safety of No. 12a lymphadenectomy for gastric cancer patients with distal or total gastrectomy
by: Yang, Kun, et al.
Published: (2016)

Long-term Survival Outcomes of Laparoscopic Versus Open Gastrectomy for Gastric Cancer: A Systematic Review and Meta-analysis
by: Chen, Xin-Zu, et al.
Published: (2015)

Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer
by: Garrett, C R, et al.
Published: (2012)

Survival Benefits With Artificial Liver Support System for Acute-on-Chronic Liver Failure: A Time Series-Based Meta-Analysis
by: Shen, Yi, et al.
Published: (2016)

Neoadjuvant chemotherapy (NCT) plus targeted agents versus NCT alone in colorectal liver metastases patients: A systematic review and meta-analysis
by: Cui, Chun-Hui, et al.
Published: (2015)

Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis
by: Coyle, C., et al.
Published: (2016)

Metformin for Clozapine Associated Obesity: A Systematic Review and Meta-Analysis
by: Siskind, Dan J., et al.
Published: (2016)

Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy
by: Mariël F. van Stee, et al.
Published: (2018-06-01)

Tissue microRNA-21 expression predicted recurrence and poor survival in patients with colorectal cancer – a meta-analysis
by: Chen, Zexin, et al.
Published: (2016)

The Effect of Metformin on Adolescents with Type 1 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Liu, Wei, et al.
Published: (2016)

No Survival Benefit from Adding Cetuximab or Panitumumab to Oxaliplatin-Based Chemotherapy in the First-Line Treatment of Metastatic Colorectal Cancer in KRAS Wild Type Patients: A Meta-Analysis
by: Zhou, Si-wei, et al.
Published: (2012)

Use of Metformin Alone Is Not Associated with Survival Outcomes of Colorectal Cancer Cell but AMPK Activator AICAR Sensitizes Anticancer Effect of 5-Fluorouracil through AMPK Activation
by: Sui, Xinbing, et al.
Published: (2014)

Effects of Metformin on CD133+ Colorectal Cancer Cells in Diabetic Patients
by: Zhang, Yanfei, et al.
Published: (2013)

Effects of metformin on colorectal cancer stem cells depend on alterations in glutamine metabolism
by: Jae Hyun Kim, et al.
Published: (2018-01-01)

Inhibitory Effect of Metformin Therapy on the Incidence of Colorectal Advanced Adenomas in Patients With Diabetes
by: Kim, Yo Han, et al.
Published: (2015)

Survival benefit and safety of the combinations of FOLFOXIRI ± bevacizumab versus the combinations of FOLFIRI ± bevacizumab as first-line treatment for unresectable metastatic colorectal cancer: a meta-analysis
by: Xu, Wei, et al.
Published: (2016)

Time lag to benefit after screening for breast and colorectal cancer: meta-analysis of survival data from the United States, Sweden, United Kingdom, and Denmark
by: Lee, Sei J, et al.
Published: (2013)

Platelet‐to‐lymphocyte ratio could be a promising prognostic biomarker for survival of colorectal cancer: a systematic review and meta‐analysis
by: Peng, Hong‐Xin, et al.
Published: (2016)

Clinical Outcomes and Quality of Life Following Surgical Treatment for Refractory Epilepsy: A Systematic Review and Meta-Analysis
by: Liu, Shi-Yong, et al.
Published: (2015)

Survival Benefit of Three Different Therapies in Postoperative Patients With Advanced Gastric Cancer: A Network Meta-Analysis
by: Dong-Mei Wu, et al.
Published: (2018-08-01)

Efficacy of Metformin for Benign Thyroid Nodules in Subjects With Insulin Resistance: A Systematic Review and Meta-Analysis
by: Miao Sui, et al.
Published: (2018-08-01)